
Keywords: BALF; bronchoalveolar lavage fluid; COPD; chronic obstructive pulmonary disease; CS; cigarette smoke; CSE; cigarette smoke extract; LAMA; long-acting muscarinic receptor antagonists; MIP-2; macrophage inflammatory protein-2; MAPK; mitogen-activated protei